论文部分内容阅读
目的探讨米索前列醇在产后出血中的临床疗效,并对其药理作用进行分析。方法将近年来在我院接收的76例产妇随机分为观察组与对照组,产后分别给予米索前列醇及缩宫素预防出血,对两组产妇产后出血量、出血发生情况进行观察,并分析其药理作用。结果观察组患者平均出血量明显少于对照组(P<0.05);观察组患者产后出血发生率明显低于对照组(P<0.05)。结论产妇产后给予米索前列醇能够有效抑制产后出血,减少产后出血的发生率。
Objective To investigate the clinical efficacy of misoprostol in postpartum hemorrhage and analyze its pharmacological effects. Methods Seventy-six maternal women received in our hospital in recent years were randomly divided into observation group and control group. Misoprostol and oxytocin were given respectively to prevent bleeding after birth. The postpartum hemorrhage and hemorrhage were observed and analyzed Its pharmacological effects. Results The average amount of bleeding in the observation group was significantly less than that in the control group (P <0.05). The incidence of postpartum hemorrhage in the observation group was significantly lower than that in the control group (P <0.05). Conclusion Maternal postnatal administration of misoprostol can effectively inhibit postpartum hemorrhage and reduce the incidence of postpartum hemorrhage.